Cited by 209Autophagy in Disease and TherapyNeurological Disorders and TreatmentsMitochondrial Function and Pathology

Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke

Li, Qiang, Zhang, Ting, Wang, Jixian, Zhang, Zhijun, Zhai, Yu, Yang, Guo-Yuan, Sun, Xiaojiang·2014·Biochemical and Biophysical Research Communications

Abstract

Rapamycin has been demonstrated to exhibit neuroprotective functions via the activation of autophagy in a cerebral ischemia model. However, the involvement of mitophagy in this process and its contribution to the protection of mitochondrial function remains unknown. The present study explored the characteristics of mitophagy after cerebral ischemia and the effect of rapamycin on mitochondrial function. Male Sprague-Dawley rats underwent transient middle cerebral artery occlusion (tMCAO). Neurological deficits scores; infarct volumes; mitophagy morphology; and the levels of malondialdehyde (MDA), adenosine triphosphate (ATP) and mitochondrial membrane potentials (Δψm) were examined. The expression of LC3, Beclin-1 and p62 in the mitochondrial fraction combined with transmission electronic microscopy were used to explore mitophagic activity after ischemia. We also blocked autophagosome formation using 3-methyladenine (3-MA) to check the linkage between the mitochondrial protective effect of rapamycin and enhanced mitophagy. We observed that rapamycin significantly enhanced mitophagy, as evidenced by the increase in LC3-II and Beclin-1 expression in the mitochondria and p62 translocation to the mitochondria. Rapamycin reduced infarct volume, improved neurological outcomes and inhibited mitochondrial dysfunction compared with the control animals (p<0.05). However, these protective effects were reversed by 3-methyladenine treatment after rapamycin. The present study indicates that…

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2014.01.032

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rapamycin treatment partially improved APOE4 astrocytes' mitochondrial function.

    “rapamycin treatment, which was shown to stimulate mitophagy40,41,53, partially improved APOE4 astrocytes’ mitochondrial function.”
  • Rapamycin promotes autophagosome formation and induces mitophagy by upregulating the parkin/PINK1 pathway.

    “rapamycin, which promotes autophagosome formation30, and was shown to induce mitophagy by upregulating the parkin/PINK1 pathway25,40–42.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, Q., Zhang, T., Wang, J., Zhang, Z., Zhai, Y., Yang, G.-Y., & Sun, X.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
  • Yang, Guo-Yuan
  • Sun, Xiaojiang
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2014-02
Volume
444
Issue
2
Pages
182-188
ISSN
0006-291X (ISSN-L)
OpenAlex
W1997801295
Cited by
209
References
6
Citations by year
2026: 12 · 2025: 17 · 2024: 11 · 2023: 23 · 2022: 22 · 2021: 18 · 2020: 25 · 2019: 23 · 2018: 19 · 2017: 16 · 2016: 12 · 2015: 8 · 2014: 3
FWCI
9.16
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical and Biophysical Research Communications (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Science and Technology Commission of Shanghai Municipality (10JC1408100)
  • National Natural Science Foundation of China (81070939, 31100783, 31171014)
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
rapamycin, mitophagy, mitochondrial dysfunction, cerebral ischemia, ischemic stroke, autophagy, LC3, Beclin-1, p62, 3-methyladenine, middle cerebral artery occlusion, neuroprotection, infarct size, mitochondrial membrane potential, oxidative stress
MeSH terms
Beclin-1, Sequestosome-1 Protein, Adenosine Triphosphate, Animals, Autophagy, Brain, Brain Ischemia, Immunohistochemistry, Immunosuppressive Agents, Male, Malondialdehyde, Membrane Proteins, Microtubule-Associated Proteins, Mitochondria, Blotting, Western, Rats, Sprague-Dawley, Sirolimus, Infarction, Middle Cerebral Artery, Stroke, Protein Transport, Microscopy, Electron, Transmission, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Rats, Membrane Potential, Mitochondrial, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review